Sander Gary E
Department of Medicine, Section of Cardiology, Louisiana State University Health Sciences Center, 1542 Tulane Avenue, New Orleans, LA 70112, USA.
Curr Hypertens Rep. 2004 Dec;6(6):469-76. doi: 10.1007/s11906-004-0043-3.
High blood pressure, once believed to represent a normal and progressive component of the aging process, is now recognized as a manifestation of structural and physiologic abnormalities of aortic function. Elevated systolic blood pressure and increased pulse pressure unquestionably increase the risk of both fatal and nonfatal cardiovascular events, including stroke, myocardial infarction, and heart failure. Isolated systolic hypertension, defined as a systolic blood pressure >/= 140 mm Hg with a diastolic blood pressure < 90 mm Hg, affects most individuals aged 60 years and older. Several clinical trials have clearly demonstrated that treatment of hypertension significantly reduces the cardiovascular event rate. However, controversy continues as to the choice of antihypertensive agents and combinations of agents. It is both appropriate and necessary to treat elderly hypertensives aggressively to the same target blood pressures identified for younger patients. It is also appropriate to initiate treatment with lower doses of antihypertensive agents and to bring the pressure down more slowly, monitoring for orthostatic hypotension, impaired cognition, and electrolyte abnormalities.
高血压曾被认为是衰老过程中正常且渐进的一部分,如今被视为主动脉功能结构和生理异常的一种表现。收缩压升高和脉压增加无疑会增加致命和非致命心血管事件的风险,包括中风、心肌梗死和心力衰竭。单纯收缩期高血压定义为收缩压≥140 mmHg且舒张压<90 mmHg,影响大多数60岁及以上的个体。多项临床试验已明确表明,高血压治疗可显著降低心血管事件发生率。然而,关于抗高血压药物的选择以及联合用药仍存在争议。积极治疗老年高血压患者至与年轻患者相同的目标血压既合适又必要。以较低剂量的抗高血压药物开始治疗并更缓慢地降低血压,同时监测体位性低血压、认知障碍和电解质异常也是合适的。